港股异动 | 中滙集团(0382.HK)涨6%创近2个月新高 机构唱好+明日发中期业绩
格隆汇4月19日丨中滙集团(0382.HK)续升6%,2日累计涨幅超12%。现报8.8港元创近2个月新高,总市值94亿港元。BNPP法巴(Morningstar晨星)发布研报上调中滙集团目标价至13港元,对应2022财年盈利的18.8倍PE。基于广东学校两个新校区四会校区和新会校区的陆续建成,加上2020年12月四川收购学校四川城市职业学院和四川城市技师学院的业绩并表,该行认为中滙集团未来5年的盈利将会有不低于32%的年复合增长。另外,公司将于4月20日(明日)举行董事会会议审批中期业绩,此前预期2021财年上半年经调整纯利同比增幅不低于30%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.